NCT01436825View on ClinicalTrials.gov

Validation Study of a cOmputer Pharmacokinetic Tool to assIst in the Follow up Care of haeMophilia A Patients

CompletedOBSERVATIONAL

Enrollment

69

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2015

Conditions

Haemophilia A

Interventions

DRUG

Recombinant Factor VIII (Kogenate FS, BAY14-2222)

Prophylactic treatment : 20-40 UI /Kg administered all 2 in 3 days .

Trial Locations (2)

Unknown

Many Locations

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY